Reports

Drug name	NICE TAs	Comments
Mannitol inhalation (Bronchitol®)	TA266 - Mannitol dry powder for inhalation for treating cystic fibrosis	Hospital only
Marstacimab (Hympavzi®)	NICE TA 1073 Marstacimab for treating severe haemophilia A or B in people 12 years and over without anti-factor antibodies
Mavacamten	TA913: Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy
Melatonin 2mg M/R tablets (Circadin®)#Amber	Melatonin ESCA for REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults	REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults
Melatonin 3mg tablets	Melatonin ESCA for REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults	REM sleep behaviour disorder and circadian rhythm sleep-wake disorder in adults
Memantine tablets	TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease	Dementia drugs ESCA
Mepolizumab (Nucala®)	TA671 - Mepolizumab for treating severe refractory eosinophilic asthma
Mepolizumab (Nucala®)#3.1	TA671 - Mepolizumab for treating severe refractory eosinophilic asthma
Methadone mixture 1mg/ml	TA114 - Methadone and buprenorphine for the management of opiod dependence
Methoxy polyethelene glycol-epoetin beta (Mircera)	TA323 - Erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating anaemia in people with cancer having chemotherapy	NHSE commissioned renal dialysis. CCG commissioned for use in cancer - NICE TA323.

University Hospitals Birmingham NHS Foundation Trust